Pharmaron Beijing Co., Ltd. Announces Resignation of Tsang Kwan Hung Benson as Independent Non-Executive Director

The board of directors of Pharmaron Beijing Co., Ltd. announced that, the Board resolved and approved, among others, the proposed by-election of independent non-executive Director of the third session of the Board. The Board hereby announces that Mr. Tsang Kwan Hung Benson has tendered a voluntary resignation from his position as an independent non-executive Director of the third session of the Board and a member of the audit committee, the remuneration and appraisal committee and the nomination committee of the Board. Pursuant to Article 13 of the Measures for the Administration of Independent Directors of Listed Companies issued by the China Securities Regulatory Commission, the consecutive terms of office of an independent director shall generally not exceed six years.

Mr. Tsang Kwan Hung Benson has served as an independent non-executive Director since November 28, 2019. As his tenure is approaching six years, Mr. Tsang Kwan Hung Benson has tendered his resignation to the Board. Following the resignation of Mr. Tsang Kwan Hung Benson, he has voluntarily agreed to continue to perform his duties as an independent non-executive Director and as a member of the relevant Board committees until the proposed by-election of a new independent non-executive Director is approved by the shareholders of the Company (the "Shareholders") at the upcoming extraordinary general meeting of the Company (the "EGM").

The resignation of Mr. Tsang Kwan Hung Benson will become effective upon the passing of the proposed by-election of a new independent non-executive Director at the EGM. Mr. Tsang Kwan Hung Benson has confirmed that he has no disagreement with the Board and there is no matter that need to be brought to the attention of the Shareholders with regard to his resignation. As at the date of this announcement, Mr. Tsang Kwan Hung Benson does not have any interest in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance nor any other matter which needs to be brought to the attention of the Shareholders.